Founded in 2015 and based in Menlo Park, California, Lagunita Biosciences is a venture capital firm that focuses on investing in early-stage companies in the ophthalmology, drug discovery, oncology, medical devices, and digital health sectors. They evaluate opportunities in key areas such as ophthalmology, protein engineering and drug discovery, surgical devices, optical diagnostics and therapeutics, and mobile health. Inspired by the diverse ecosystem of their namesake in Silicon Valley, Lagunita Biosciences nurtures ideas into great companies, providing protection and support during the vulnerable stages of their development.